Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Cell & Gene Therapy Virtual Event Advertise Mailing List ATTEND Show Overview Who Attends Fierce 15 Awards Stay Updated COMMUNITIES Drug Development Clinical BD&L Trial Master File PR & Communications PROGRAM Meet the Speakers Full Agenda Drug Development Clinical BD&L Trial Master File PR & Communications Advisory Board VENUE Encore Boston Harbor Hotel & Casino PARTNERS 2026 Partner Opportunities Become a Partner 2026 CALL FOR SPEAKERS Stay Ahead of the Breakthroughs ATTEND Show Overview Who Attends Fierce 15 Awards Stay Updated COMMUNITIES Drug Development Clinical BD&L Trial Master File PR & Communications PROGRAM Meet the Speakers Full Agenda Drug Development Clinical BD&L Trial Master File PR & Communications Advisory Board VENUE Encore Boston Harbor Hotel & Casino PARTNERS 2026 Partner Opportunities Become a Partner 2026 CALL FOR SPEAKERS Stay Ahead of the Breakthroughs Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Cell & Gene Therapy Virtual Event Advertise Mailing List Powerhouse Communities: Drug Development Home Clinical Home BD&L Home Trial Master File Home PR & Comms Home Please check back regularly as we are adding new speakers on a daily basis. Shmuel Agus Chief Medical Officer Diadem Diagnostics Murray Aitken Executive Director IQVIA Institute for Human Data Science Brian Alexander, MD, MPH CEO Valo Health Tyler Allchin Managing Director, Healthcare JobsOhio Lindsey Allen Vice President, Investor Relations & Communications Amylyx Pharmaceuticals, Inc. Kevin Anderson Sr. Director, Clinical Operations, Therapeutics Moderna Priya Annamalai Director, Inspection Program - Quality Assurance Astellas Pharma Global Development, Inc. Christopher Arendt Chief Science Officer, Head of Research Takeda Arran Attridge Former Senior Vice President, Corporate Communications Vir Biotechnology Ashley Avery Senior Specialist, Quality Documents & Archival AbbVie Behtash Bahador Senior Director, Community Engagement & Partnerships CISCRP Sara Jane Baker General Manager, Head of North America DNA Communications Steven Barrett Partner WilmerHale Tuba Bas Senior Director, Clinical Center of Excellence Bristol Myers Squibb Subha Basu Managing Director Converge Advisory Group Natalie Beck Senior Manager, Clinical Trials and RWD Genome Medical Wendy Beeby Former Head, Clinical Trial Associated Takeda Lyla Bibi Partner Goldman Sachs Fritz Bittenbender Senior Vice President and Head of Public Affairs & Access Genentech Hans Bitter, PhD Head, Computational Science and Data Strategy Takeda Joseph Bolster Associate Director, TMF Operations Prothena Biosciences Steffen-Sebastian Bolz Founder & CSO Aphaia Pharma Ariel Bourla Head of Solid Tumor Oncology, Data Science & Digital Health, Research & Development Johnson&Johnson Stephen Boyer, PhD Founder and Principal Consultant ( Ex- Alkermes Vice President, Head of Regulatory Strategy) Regulatory Science Insights Jared Brooslin Senior Manager, Trial Master File Intellia Therapeutics Kevin Brophy Life Science Industry Advisor SAP Vicky Brown U.S. Therapeutic Area Head for Oncology and Emerging Areas Boehringer Ingelheim Kerry Bryant Lead, R&D Leadership Communications & Employee Engagement Takeda Karim Budhwani CEO-Scientist CerFlux Kristin Cahill Global CEO GCI Health Brian Campion VP, Business Development Regulus Therapeutics Alex Canale Managing Director GCI Group Deborah Castellana Former Director, Clinical Trial Documentation & Archival Bristol Myers Squibb Helen Chalk Former VP, Clinical Operations Mythic Therapeutics Moitreyee Chatterjee-Kishore Head of Oncology Development Astellas Pharma Inc. Rahul Chaturvedi CEO and Co-founder/Host of the Biotech 2050 podcast Clora Amita Chaudhari Vice President, Head of North America Regulatory Daiichi Sankyo Catherine Cheung Director of Clinical Operations Gilead Science Ivan Cheung CEO NextPoint Therapeutics Giacomo Chiesi Executive Vice President, Chiesi Global Rare Diseases Chiesi Group Jenna Cohen Vice President, Investor Relations and Global Business Communications Blueprint Medicines Viswa Colluru CEO & Founder Enveda Lee Cooper Managing Director Delos Capital Gavin Corcoran, MD Chief Development Officer at Formation Bio Grace Crawford Global Head, Clinical Quality Management AstraZeneca Maureen Cunningham Senior Director, Clinical Oversight, Systems and Training United Therapeutics, Corp. Chris Cutie, M.D. Vice President, Disease Area Leader, Bladder Cancer Johnson & Johnson Innovative Medicine Monique da Silva SVP, Corporate Affairs AnaptysBio Steven Damon CEO Micron Biomedical Marianne De Backer CEO Vir Biotechnology Siegrid Delgadillo Director, eTMF services Premier Research Ashlyn Deshaies Director, Clinical and TMF Operations TG Therapeutics Lindy Devereux Vice President, Communications Flagship Pioneering Punit Dhillon President and CEO Skye Bioscience Valentina Dilda Former Director of Clinical Innovation and Transformation Cerevel/AbbVie Becky Dion Enterprise Reference Model Lead Novartis Meg Dodge Senior Vice President, External Affairs Rocket Pharmaceuticals, Inc. Eleanor Duff Senior Vice President, Global Corporate Communications, BeOne Medicines BeOne Medicines Nathan Edwards Associate Engagement Manager Arya Consulting Partners Vinay Edwin Director, Clinical Quality Lead Pharvaris Andrea Engel Senior Director, Head, Cell and Delivery Systems Evonik Hannah England Partner Ropes & Gray Debbie Etchison Executive Director, Head of Corporate Affairs Alkeus Pharmaceuticals Tom Farrand CEO & Co Founder Delfa Amy Fesmire-Baus Associate Director, Patient Engagement and Recruitment – TA Lead Bristol Myers Squibb Alicia Fiscus SVP, Head of Global Regulatory Affairs & GCP/GLP Quality Assurance Rhythm Pharmaceuticals Melissa Flanagan Sr. Manager, Global TMF & Records Management BeOne Medicines USA Inc. (Formerly BeiGene USA, Inc.) Bradford Flint Partner Ropes & Gray Belén Fraile, M.D., MSc, MBA Chief R&D Data Science Officer Johnson & Johnson Innovative Medicine Stephen Framil Corporate Global Head of Accessibility Merck & Co., Inc. Robert Gabbay Former Chief Scientific & Medical Officer American Diabetes Association Margo Georgiadis Co-founder & CEO Montai Therapeutics; Flagship Pioneering Alan Ginsberg Vice President, Head of Global Licensing & Business Development, New Therapeutic Areas EMD Serono Sherry Goldberg President, North America GCI Health Gregory Goldmacher Associate VP, Clinical Research Merck Pauline Goldsmith-Johnson DEI Strategist Regeneron Linda Goodman Co-Founder Fauna Bio Olga Granaturova Managing Partner & CoFounder ANAMAX Innovation & PriveBio Craig Granowitz M.D., Ph.D. Senior Vice President and Chief Medical Officer Lexicon Pharmaceuticals Gabriela Graterol Associate Director of Clinical Quality Assurance Astellas Michael Greene Principal, SAP Business Apps Practice Lead Answerthink Zahiah (Zee Zee) Gueddar Senior Director, Commercialization IQVIA Technologies Rahul Gupta President GATC Health Rebecca Halbur Associate Director, TMF Records Mangement, Cinical Trial Systems & Operations Moderna Janet Hammond Chief Development Officer Atea Pharmaceuticals Jamie Harrop Vice President Clinical Operations Beam Therapeutics Paul Hastings CEO Nkarta, Inc.; Ex-Chair, Biotechnology Innovation Organization Sheela Hegde Managing Partner & Global Head Health Advances Devora Henderson President Elevate Clinical Research Charlotte Hillan Programme Lead Teckro Etienne Hinton TMF System Specialist Duke University Health System Tom Hopkins Vice President, Head, ExploR&D Eli Lily & Company Tonia Huggins Director, R&D Business Systems and Ops Management Daiichi Sankyo Eric Hughes Global R&D head and Chief Medical Officer Teva Christelle Huguet Executive Vice President, Head of R&D Ipsen Robyn Hunter Chief Financial Officer SOTIO Troy Ignelzi CFO Rapport Therapeutics Darren Incorvaia Staff Writer Fierce Biotech Laura Indolfi, Ph.D. Co-founder & CEO PanTher Therapeutics Erik Ingelsson, MD, PhD Chief Scientific Officer Wave Life Sciences Cynthia Isaac, PhD Group Managing Director, Corporate Affairs Practice Syneos Health Communications Ramya Iyer Sr. Manager, TMF Development Records Management | Development Operations & Portfolio Management Regeneron Friedemann Janus SVP, Head of Regional Business Development & Licensing, Co.Lab and Divestitures Bayer O'Tika Jones Senior Specialist, Business Ops Management – TMF Daiichi Sankyo, Inc. Jose Juves SVP, Corporate and Patient Affairs Dyne Therapeutics Alex Kadet Chief Business Officer Gero.ai Chiedza Kaitano Vice President and Global Program Head for Obesity Regeneron Dawn Kalmar Chief Communications Officer Stoke Therapeutics Vikram Kansra Founder & CEO Vicero Bio Fraiser Kansteiner Associate Editor Fierce Pharma Jason Kantor Chief Business Officer Nurix Therapeutics Daniel Karlin Chief Medical Officer MindMed Nandini Kashyap Conference Director, Fierce Life Sciences Andrea Kaufmann Senior Director, Life Sciences & Healthcare Global Marketing SAP Lindsay Kehoe Senior Project Manager and Lead Emerging Programs Clinical Trials Transformation Initiative Nida Khan Founder & President Arya Consulting Partners Carter King Executive Vice President, Business Development Protagonist Therapeutics Jade King Vice President US Commercial Communications GSK Jim Koers Associate Vice President, Head of Due Diligence Eli Lilly and Company Olga Kolman Head of US Emerging Portfolio Strategy Servier Pharmaceuticals Jennifer Krohn Associate Director, Clinical Operations, RBQM Gilead Sciences John Lacey Lead, Corporate R&D and Science Communications Takeda Andrew Lam Managing Director, Head of Biotech Private Equity Ally Bridge Group V. Tyrone Lam Chief Business Officer GATC Health Mankit Law Senior Director, Business Development, Search & Evaluation GSK Erin Leckrone Vice President, Clinical Trials National Marrow Donor Program (NMDP) Jennifer Lee EVP, Clinical Operations and Quality Assurance Novita Pharmaceuticals Gene Lee, PhD Chief Technical Officer AltruBio Inc. Mark Leney, PhD Senior Advisor, Science, CMC and Technical Operations Uniphar John Lepore CEO ProFound Therapeutics Liz Leveille Vice President, BD&L, Head of Boston and European Innovation Hubs & Discovery Transactions Merck Jeremy Levin Chairman and CEO Ovid Therapeutics Steve Levine Chief Patient Officer Compass Pathways Raven Lin Co-Founder & CEO Pilatus Biosciences Angus Liu Deputy Editor Fierce Pharma Levi Loft Clinical Trial Manager Zevra Therapeutics Scott Lohr Senior Vice President, Informatics. Program Director of Chronos, Alkahest, A Grifols Company Matt Lowery Clinical Research & Site Expert The Pathways Grp, LLC Caitlin Lowie VP, Corporate Communications and Investor Relations Ardelyx Dawn Lundin Former Vice President of Global Quality Lykos Therapeutics Karla MacDonald Chief Corporate Affairs Officer Entrada Therapeutics Edoardo Madussi Senior Director, Business Development & Strategic Initiatives Intelligencia Paige Mahaney, Ph.D., Chief Scientific Officer C4 Therapeutics Parag Mallick, PhD Chief Scientist Nautilus Biotechnology Becky Malone Communications Lead, U.S. Epilepsy & Rare Syndromes UCB Harish Manmathan Sr. Director Trial Data Strategy Takeda Rao V. Mantri Chief Manufacturing officer Astellas John Maraganore, PhD Founding CEO, Alnylam Pharmaceuticals; CEO and Principal, JMM Innovations Paula Markos Director II, RDQA Inspection Management AbbVie Megan Mason Implementation Manager, Global Process Development Lonza Gabrielle Masson Senior Editor Fierce Biotech Lindsay Mateo CCO Weave Katie McCarthy Senior Vice President & Practice Lead, Clinical & Regulatory Services Lumanity Jake McDonald TMF Solutions Consultant Cencora John McDonough Executive Chairman & Chief Executive Officer Sunbird Bio Matt McKendrick Manager GCP Excellence in Clinical Trials Takeda Paige Meade Gonzales Associate Director, Clinical Trial Analytics Bristol Myers Squibb Jeffery Meckler CEO Indaptus Therapeutics Nell Meosky Luo Founder & CEO Folia Health Lauren Merrill Director of TMF and R&D Records Management Biogen Jennifer Michaelson, Ph.D. Chief Scientific Officer Cullinan Therapeutics Liza Micioni Sr. Director, Head of Clinical Operations Tris Pharma, Inc. Anthony Mikulaschek Vice President, DPS Patient Commercial Strategy IQVIA Technologies Judith Millard Vice President, Enterprise Account Leader Parexel Chad Miller Chief Technology Officer ResVita Bio Greg Miller Chief Business Officer Parabilis Medicines Annie Mitsak Partner Cure Ventures P K Morrow Senior Vice President and Head of Oncology Therapeutic Area Unit Takeda Curran Murphy Senior Director Clinical Operations / Head of Clinical Business Operations Blueprint Medicines John Murphy Chief Scientific Officer Arbor Biotechnologies Nikhil Mutyal Head of Search and Evaluation - Respiratory & Immunology Head of Search and Evaluation - Respiratory & Immunology AstraZeneca Mike Nally CEO Generate Biomedicines Sahm Nasseri SVP Business Development & Strategy Generate Biomedicines Tom Neyarapally CEO and Co-Founder Archetype Therapeutics Thong Nguyen Senior Engagement Manager, R&D Consulting Syneos Health Daniel O'Connell Partner Novo Holdings Kemi Olugemo Chief Medical Officer Korro Bio Tim Opler Managing Director, Biopharma Stifel Marie O’Farrell, PhD Senior Vice President of Research and Development Sagimet Biosciences Rita Pease Head of Quality Assurance Harbor Clinical Oksana Petrushyna Sr. Data Scientist - Metrics, Analytics & Performance (MAP) Merck Stephanie Pfister Vice President, Clinical Operations Biohaven Raviv Pryluk CEO & Co Founder PhaseV Christine Purcell Senior Specialist, Business Ops Management-TMF, Global Development Information Management, R&D Strategy & Operations Daiichi Sankyo, Inc. Adrian Quartel Chief Medical Officer Zevra Therapeutics Maha Radhakrishnan Executive Partner, Private Equity Sofinnova Investments Akshay Rai Principal, Healthcare & Biotech Investments Premji Invest Simmi Rana Associate Director, Records Management Viridian Therapeutics Jeff Raphael Managing Partner OmniScope Partners Bhaskar Rege, PhD Senior Vice President, Pharmaceutical and Early-Stage Development Alkermes Jorge Reis Filho Chief AI and Data Scientist AstraZeneca Maria Restrepo Program Director, Diversity in Clinical Trials Medtronic Jennifer Ribeiro Clinical Trial Operations Process Leader and Expert Sara Riordan Vice President, Strategy Genome Medical Jackie Roberts Manager, GCP Excellence in Clinical Trials Takeda Keith Lee Robinston CIO Repligen Kevin Rooney, Ph.D. Director, AI Transformation IQVIA Michael Rossi Former President and CEO Y-mAbs Carsten Rudolph Co-Founder & CEO Ethris Sarah Ruiz Clinical Strategist Kivo Fatima Sabar CEO & Founder Bluenote Sameer Sabir Co-Founder & CEO Brixton Biosciences Christina Salinas Manager, Trial Master File BioNTech Amber Salzman, Ph.D. CEO Epicrispr Biotechnologies Scott Saywell EVP, Corporate Development Coherus Oncology John Scarlett Former CEO Geron David Schaffer Professor; Director of QB3; Director of Bakar BioEnginuity Hub UC Berkeley Kelly Schlemm Head of Corporate Affairs Servier Pharmaceuticals Laurel-Ann Schrader Director, Client Solutions TransPerfect Rich Segal Partner Cooley, LLP Christy Shaffer General Partner Hatteras Venture Partners Esther Shamir Clinical Operations Strategist Hemab Therapeutics Chris Shoel Director, R&D Consulting Syneos Health Sidd Shrivastava, PhD SVP, Head of CMC and Global Technical Operations Cue Biopharma Mridula Shukla Sr. Director / Head of Genetic Medicines, Regulatory Affairs Roche - Genentech George Shuster Chair, Debt Finance Practice WilmerHale Shannon Simpson Associate Director, Trial Master File (TMF) Lead Lexicon Pharmaceuticals Andres Sirulnik Senior Vice President, Clinical Development Unit Head, Hematology Regeneron Hunter Smith CFO Rhythm Pharmaceuticals Jeremy Springhorn CEO Nido Biosciences Brad Stefanovic Head of Clinical Innovation Simulations Plus Tadaaki Taniguchi Chief R&D Officer Astellas Angela Teliha Former Director, TMF Operations Prothena Biosciences Jasmine Thangaraj eTMF Manager, TMF Records Management Moderna Charles Theuer M.D. Ph.D. Chief Medical Officer Halozyme Helen Torley President and CEO Halozyme Therapeutics Jamie Marie Toth Global Head, TMF Management & Records BeOne Medicines USA Inc. (Formerly BeiGene USA, Inc.) Mohit Trikha Board Member President & COO Kivu Bioscience John Truesdell Chief Business Officer Foresight Diagnostics Mohan Uttarwar CoFounder & CEO 1Cell.AI Sarah von Braun Manager, Trial Master File BioNTech Yaming Wang Managing Director Alphabet Consulting Leah Weitz Sr Product Manager, Life Sciences - Clinical Egnyte John Westwood Senior Vice President Lumanity Kirsty Whelan Managing Director, Strategy /prompt Kym White SVP and Chief Corporate Affairs Officer Generate:Biomedicines Sarah White Executive Director The MRCT Center of Brigham and Women’s Hospital and Harvard Laura Whitmore Senior Director, Business Operations and Clinical Outsourcing Kailera Therapeutics Jane Williams Vice President, Medical Management Syneos Health Renee Williams Chief Business Officer Signify Bio Melisa Williamson Director, Quality Assurance PharPoint Research Meredith Wilson Head, Advocacy & Patient Affairs Syneos Health Sam Windsor CEO Ignota Labs Heather Wolff Vice President, Development Operations Sionna Therapeutics Alina Worth Managing Director Biosector 2 Kelli Wright Director, Patient Advocacy Day One Biopharmaceuticals Hamish Wright, Ph.D. Senior Vice President, Translational Science and Therapeutics Business Development Schrödinger Sandeep Yadav, Ph.D. VP, Technical Development Sangamo Therapeutics Ben Yerxa President Opus Genetics Yinfei Yin Senior Vice President and Head of Biology, BD, and Marketing ChemPartner Jonathan York Vice President Global Business Development Daiichi Sankyo Alethia Young Chief Financial Officer Bicycle Therapeutics Hanadie Yousef Co-Founder and CEO Juvena Therapeutics Alex Zhavoronkov CEO Insilico Medicine Jimmy Zhuang Assistant General Counsel, Business Development Novo Nordisk Toban Zolman CEO Kivo VIEW THE FULL AGENDA